1,4-Dithiothreitol structure
|
Common Name | 1,4-Dithiothreitol | ||
|---|---|---|---|---|
| CAS Number | 16096-97-2 | Molecular Weight | 154.251 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 364.5±42.0 °C at 760 mmHg | |
| Molecular Formula | C4H10O2S2 | Melting Point | 42-44ºC | |
| MSDS | Chinese USA | Flash Point | 174.2±27.9 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 1,4-DithiothreitolL-Dithiothreitol is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | L-1,4-dithiothreitol |
|---|---|
| Synonym | More Synonyms |
| Description | L-Dithiothreitol is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 364.5±42.0 °C at 760 mmHg |
| Melting Point | 42-44ºC |
| Molecular Formula | C4H10O2S2 |
| Molecular Weight | 154.251 |
| Flash Point | 174.2±27.9 °C |
| Exact Mass | 154.012222 |
| PSA | 118.06000 |
| LogP | 0.07 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.579 |
| Storage condition | −20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H315-H319-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R21/22 |
| Safety Phrases | 26-36/37 |
| RIDADR | UN 3335 |
| WGK Germany | 3 |
| RTECS | EK1612000 |
| Hazard Class | 9.0 |
| HS Code | 2930909090 |
|
~82%
1,4-Dithiothreitol CAS#:16096-97-2 |
| Literature: Lee, Sang Hyup; Kohn, Harold Heterocycles, 2003 , vol. 60, # 1 p. 47 - 56 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2930909090 |
|---|---|
| Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
Cancer Prev. Res. (Phila.) 8(3) , 208-21, (2015) Exposure to toxicants leads to cumulative molecular changes that overtime increase a subject's risk of developing urothelial carcinoma. To assess the impact of arsenic exposure at a time progressive m... |
|
|
The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
PLoS ONE 9(5) , e97697, (2014) Patients with ER/HER2-positive breast cancer have a poor prognosis and are less responsive to selective estrogen receptor modulators; this is presumably due to the crosstalk between ER and HER2. Fatty... |
|
|
Matrix stiffening and β1 integrin drive subtype-specific fibroblast accumulation in lung cancer.
Mol. Cancer Res. 13(1) , 161-73, (2015) The crucial role of tumor-associated fibroblasts (TAF) in cancer progression is now clear in non-small cell lung cancer (NSCLC). However, therapies against TAFs are limited due to a lack of understand... |
| Cleland reagent chiral |
| 2,3-Butanediol, 1,4-dimercapto-, (2R,3R)-rel- |
| (2R,3R)-1,4-Disulfanyl-2,3-butanediol |
| 1,4-Dithiothreitol |
| L-(−)-Dithiothreitol |
| 1,4-Bissulfanylbutane-2,3-diol |
| DL-1,4-Dimercapto-2,3-dihydroxybutane |
| (2R,3R)-(-)-2,3-Dihydroxy-1,4-butanedithiol |
| 1,4-Disulfanyl-2,3-butanediol |
| (R*,R*)-1,4-DIMERCAPTO-2,3-BUTANEDIOL |
| (2R,3R)-1,4-Disulfanylbutane-2,3-diol |
| 2,3-Butanediol, 1,4-dimercapto-, (2R,3R)- |
| L-Dithiothreitol |
| EINECS 240-263-0 |
| (2R*,3S*)-1,4-dimercaptobutane-2,3-diol |
| dithiothreitol |
| threo-2,3-Dihydroxy-1,4-butanedithiol |
| (−)-Cleland's Reagent |
| (2R*,3S*)-1,4-dimercapto-2,3-butanediol |
| (2R,3R)-(-)-1,4-Dimercapto-2,3-butanediol |
| (2R,3R)-1,4-Dimercapto-2,3-butanediol |
| UNII:T8ID5YZU6Y |
| L-Cleland's |
| 1,4-Disulfanylbutane-2,3-diol |
| 2,3-Butanediol, 1,4-dimercapto- |
| (±)-1,4-Dimercapto-2,3-butanediol |
| (2R,3R)-1,4-dimercaptobutane-2,3-diol |
| MFCD00064305 |